Omicron covid-19 variant

There are more than 2.8 million confirmed cases of coronavirus worldwide now, and more than 50 countries have reported at least 1,000 deaths related to COVID-19. The World Health Organization (WHO) also reports over 879,000 patients have lost their lives till and nearly 14.7 million people and businesses have been affected by this disease. Despite the severe toll from COVID-19 across the globe, it appears that vaccines could potentially provide protection against the new SARS-CoV-2 variant causing a range of symptoms. Pfizer’s, Modern a’s, and AstraZeneca’s, among others, are the Vaccines currently being used in the U.S. 

 

Research shows on COVID-19 vaccines is still quite limited, with only about 15% of scientists participating in clinical trials and Phase 3 studies (test results that involve many participants) reporting a successful vaccine efficacy. This does not mean that there will be no success in developing new products for prevention. Several recent publications show promise but none have yet been peer-reviewed in full. the United Kingdom, South Africa, and Brazil” found that while antibodies that recognize the spike protein did not detect these two variants. I believe that such findings would change how we view the vaccine. However, several studies in both humans and animals have shown promising results using other antibodies as well as multiple other types of vaccine candidates.

If those who have been infected do become infectious, then even those who have previously received vaccine infection can unwittingly pass the virus for a longer period to others. Such conditions are already happening today with the Delta variant. And with new mutations of the virus continually emerging, even if scientists identify and understand them, Different versions of the same variant will develop in near future. These viruses constantly exist within our environment and cannot be easily controlled. At my age, I am currently working out regularly and taking my medication daily.

 

As we know, people are more susceptible to falling seriously ill than they are to falling ill when first infected by these variants. One can assume that the most vulnerable — including doctors and nurses — may be among the top ten targets for a newly emerging version of the virus during the coming months. Some experts believe that the risk of getting the virus falls with each strain. Regardless of their specific risks, the CDC warns that the safety of the vaccine becomes highly critical to prevent potential side effects in high-risk groups.

 

It looks like we are now headed towards another round of lockdowns, restrictions, and school closures in the U.S. and elsewhere. For me, I think that we need to stay vigilant if we want to avoid more widespread death and illness due to COVID-19. People will need to make sure that they wear masks, wash their hands often, maintain safe social distancing guidelines and work from home whenever possible. I suppose that we can say that we will probably start wearing masks again when schools reopen for in-person classes.